Skip to content

    BASF India

    BASFGood
    Chemicals·22 May 2024
    Management Summary

    BASF India delivered a strong performance in FY24, characterized by significant profit expansion despite flat revenue growth. The company successfully navigated a challenging global environment marked by China overcapacity and pricing pressure in upstream chemicals. Growth was primarily driven by the Agricultural Solutions segment and strong volume growth in downstream businesses, which offset negative price realizations.

    Highlights

    8

    • Full-year Revenue reached ₹13,768 crores, a marginal 1% increase YoY despite significant pricing headwinds.

    • Q4 PBT (before exceptional items) more than doubled YoY to ₹219 crores, marking the third-best quarterly result in company history.

    • Full-year EPS grew significantly to ₹130 per share compared to ₹90 in the previous fiscal year.

    • Agricultural Solutions segment was the primary profit driver, contributing ₹205 crores to the total ₹230 crores EBIT improvement for the year.

    • ROCE stood at a robust 26% for the full year, with RONA (Return on Net Assets) at 29% when excluding cash surpluses.

    • The Board recommended a dividend of ₹15 per share (150% of face value).

    • Net Working Capital was maintained at ~₹1,000 crores despite revenue growth, reflecting disciplined inventory and receivable management.

    • Capacity utilization across plants remained high at 80% to 85%.

    Concerns

    2

    • China Overcapacity and Dumping

    • Vitamin A Pricing Pressure

    What Changed1

    vs Q2 FY25

    Guidance items4 → 3 (-1)

    Key financials

    Single quarter

    05 metrics
    1. 01Revenue₹13,768 Cr+1%YoY
    2. 02PBT before Exceptional Items₹219 Cr+100%YoY
    3. 03EPS₹130+44%YoY
    4. 04ROCE26%
    5. 05Net Working Capital₹1,000 Cr0%YoY

    Segment breakdown

    Agricultural Solutions
    ₹2,000 Cr Revenue14% Revenue Share₹205 Cr EBIT Contribution to Growth
    Chemicals
    -17% Revenue Growth₹1,700 Cr Revenue
    Nutrition and Care
    ₹36 Cr Segment Profit₹100 Cr Previous Year Profit
    List

    Guidance & targets

    3
    CategoryTargetPriority
    Other
    Renewable Electricity Usage (Mangalore)
    90%
    		High
    Other
    CSR Kids Lab Participation
    3000
    		High
    Capacity
    Capacity Utilization
    80-85%
    		Medium

    Risks & concerns

    4
    RiskSeverity

    China Overcapacity and Dumping

    Excess capacity in China is leading to dumping in India, keeping upstream chemical margins under heavy pressure. — Management acknowledged

    high

    Vitamin A Pricing Pressure

    Vitamin A prices have been under significant pressure, causing the Nutrition and Care segment profit to drop from ₹100 cr to ₹36 cr. — Management acknowledged

    high

    Red Sea Logistics Disruptions

    Potential for delays and increased costs in shipments for businesses dependent on imports. — Management acknowledged

    medium

    Areas of Evasion(1)

    • Specific capacity utilization numbers for individual sites (stated as a policy not to disclose).

    Q&A highlights

    3

    “We placed our product more closer to application timing also allowing us to shift the products to the right places in the country where it is needed... that has allowed us really to be able to react nicely and not to sit with too much Channel inventory.”

    Explains how BASF outperformed the sector by managing inventory tightly and focusing on high-margin new launches (Exponus, Efficon) rather than volume dumping.

    asked by Archit Joshi, B&K Securities

    2 min read5 chapters

    Detailed Narrative

    01

    Agricultural Solutions: The Engine of Growth

    The Agricultural Solutions segment reached ~₹2,000 crores in revenue, representing 14% of total sales. More importantly, it was the standout profit driver, contributing ₹205 crores to the company's total ₹230 crore EBIT improvement. This was achieved through a strategic focus on 'blockbuster' insecticide launches like Exponus and the new Efficon, alongside disciplined channel inventory management that avoided the 'dumping' seen elsewhere in the industry.

    02

    Upstream Margin Compression vs. Downstream Resilience

    A clear divergence emerged between upstream and downstream businesses. Upstream Chemicals saw a 17% revenue decline to ₹1,700 crores due to global overcapacity and Chinese dumping. Conversely, downstream segments like Coatings and Materials remained resilient, benefiting from India's 'momentum' in automotive (4% projected growth) and infrastructure spending. While input costs fell, pricing pressure remains a persistent headwind in commoditized segments.

    03

    Operational Excellence and Working Capital Discipline

    BASF demonstrated exceptional capital efficiency, maintaining Net Working Capital at approximately ₹1,000 crores even as sales grew from ₹9,500 crores to over ₹13,600 crores in recent years. Inventory is managed at ~70 days and receivables at ~65 days. This discipline supported a high ROCE of 26% and a RONA of 29%, allowing the company to fund operations and dividends from internal accruals without new borrowing.

    04

    Nutrition and Care Facing Vitamin A Headwinds

    The Nutrition and Care segment faced significant profitability challenges, with profits falling to ₹36 crores from ₹100 crores in the previous year. This was primarily attributed to severe price erosion in Vitamin A. Management noted that while volumes are developing nicely in care chemicals (UV filters, optical brighteners), the product mix currently favors lower-margin commoditized products over high-margin specialties.

    05

    Strategic Investments and Capacity Utilization

    The company is operating at a high overall capacity utilization of 80-85%. FY24 capex was modest at ₹100 crores, primarily for maintenance. However, management highlighted recent expansions like the second dispersion line in Dahej (already full) and the new E-coat facility in Mangalore. They are now evaluating debottlenecking opportunities for FY25 to cater to growing domestic demand in the automotive and construction sectors.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.